<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
    <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
    <link rel="manifest" href="/site.webmanifest">
    <link rel="mask-icon" href="/safari-pinned-tab.svg" color="#5bbad5">
    <meta name="msapplication-TileColor" content="#da532c">
    <meta name="theme-color" content="#ffffff">
    <title>Awesome Glp1 (glp1guide/awesome-glp1) Overview - Track Awesome List</title>
    <meta property="og:url" content="https://www.trackawesomelist.com/glp1guide/awesome-glp1/readme/" />
    <meta property="og:type" content="summary" />
    <meta property="og:title" content="Awesome Glp1 Overview" />
    <meta property="og:description" content="Awesome resources around the GLP1 Receptor Agonist class of treatments. Sponsored by GLP1.Guide" />
    <meta property="og:site_name" content="Track Awesome List" />
    <style>
      main {
        max-width: 1024px;
        margin: 0 auto;
        padding: 0 0.5em;
      }
      :root,[data-color-mode=light][data-light-theme=light],[data-color-mode=dark][data-dark-theme=light]{--color-canvas-default-transparent:rgba(255,255,255,0);--color-prettylights-syntax-comment:#6e7781;--color-prettylights-syntax-constant:#0550ae;--color-prettylights-syntax-entity:#8250df;--color-prettylights-syntax-storage-modifier-import:#24292f;--color-prettylights-syntax-entity-tag:#116329;--color-prettylights-syntax-keyword:#cf222e;--color-prettylights-syntax-string:#0a3069;--color-prettylights-syntax-variable:#953800;--color-prettylights-syntax-string-regexp:#116329;--color-prettylights-syntax-constant-other-reference-link:#0a3069;--color-fg-default:#24292f;--color-fg-muted:#57606a;--color-canvas-default:#fff;--color-canvas-subtle:#f6f8fa;--color-border-default:#d0d7de;--color-border-muted:#d8dee4;--color-neutral-muted:rgba(175,184,193,.2);--color-accent-fg:#0969da;--color-accent-emphasis:#0969da;--color-danger-fg:#cf222e}@media (prefers-color-scheme:light){[data-color-mode=auto][data-light-theme=light]{--color-canvas-default-transparent:rgba(255,255,255,0);--color-prettylights-syntax-comment:#6e7781;--color-prettylights-syntax-constant:#0550ae;--color-prettylights-syntax-entity:#8250df;--color-prettylights-syntax-storage-modifier-import:#24292f;--color-prettylights-syntax-entity-tag:#116329;--color-prettylights-syntax-keyword:#cf222e;--color-prettylights-syntax-string:#0a3069;--color-prettylights-syntax-variable:#953800;--color-prettylights-syntax-string-regexp:#116329;--color-prettylights-syntax-constant-other-reference-link:#0a3069;--color-fg-default:#24292f;--color-fg-muted:#57606a;--color-canvas-default:#fff;--color-canvas-subtle:#f6f8fa;--color-border-default:#d0d7de;--color-border-muted:#d8dee4;--color-neutral-muted:rgba(175,184,193,.2);--color-accent-fg:#0969da;--color-accent-emphasis:#0969da;--color-danger-fg:#cf222e}}@media (prefers-color-scheme:dark){[data-color-mode=auto][data-dark-theme=light]{--color-canvas-default-transparent:rgba(255,255,255,0);--color-prettylights-syntax-comment:#6e7781;--color-prettylights-syntax-constant:#0550ae;--color-prettylights-syntax-entity:#8250df;--color-prettylights-syntax-storage-modifier-import:#24292f;--color-prettylights-syntax-entity-tag:#116329;--color-prettylights-syntax-keyword:#cf222e;--color-prettylights-syntax-string:#0a3069;--color-prettylights-syntax-variable:#953800;--color-prettylights-syntax-string-regexp:#116329;--color-prettylights-syntax-constant-other-reference-link:#0a3069;--color-fg-default:#24292f;--color-fg-muted:#57606a;--color-canvas-default:#fff;--color-canvas-subtle:#f6f8fa;--color-border-default:#d0d7de;--color-border-muted:#d8dee4;--color-neutral-muted:rgba(175,184,193,.2);--color-accent-fg:#0969da;--color-accent-emphasis:#0969da;--color-danger-fg:#cf222e}}[data-color-mode=light][data-light-theme=dark],[data-color-mode=dark][data-dark-theme=dark]{--color-canvas-default-transparent:rgba(13,17,23,0);--color-prettylights-syntax-comment:#8b949e;--color-prettylights-syntax-constant:#79c0ff;--color-prettylights-syntax-entity:#d2a8ff;--color-prettylights-syntax-storage-modifier-import:#c9d1d9;--color-prettylights-syntax-entity-tag:#7ee787;--color-prettylights-syntax-keyword:#ff7b72;--color-prettylights-syntax-string:#a5d6ff;--color-prettylights-syntax-variable:#ffa657;--color-prettylights-syntax-string-regexp:#7ee787;--color-prettylights-syntax-constant-other-reference-link:#a5d6ff;--color-fg-default:#c9d1d9;--color-fg-muted:#8b949e;--color-canvas-default:#0d1117;--color-canvas-subtle:#161b22;--color-border-default:#30363d;--color-border-muted:#21262d;--color-neutral-muted:rgba(110,118,129,.4);--color-accent-fg:#58a6ff;--color-accent-emphasis:#1f6feb;--color-danger-fg:#f85149}@media (prefers-color-scheme:light){[data-color-mode=auto][data-light-theme=dark]{--color-canvas-default-transparent:rgba(13,17,23,0);--color-prettylights-syntax-comment:#8b949e;--color-prettylights-syntax-constant:#79c0ff;--color-prettylights-syntax-entity:#d2a8ff;--color-prettylights-syntax-storage-modifier-import:#c9d1d9;--color-prettylights-syntax-entity-tag:#7ee787;--color-prettylights-syntax-keyword:#ff7b72;--color-prettylights-syntax-string:#a5d6ff;--color-prettylights-syntax-variable:#ffa657;--color-prettylights-syntax-string-regexp:#7ee787;--color-prettylights-syntax-constant-other-reference-link:#a5d6ff;--color-fg-default:#c9d1d9;--color-fg-muted:#8b949e;--color-canvas-default:#0d1117;--color-canvas-subtle:#161b22;--color-border-default:#30363d;--color-border-muted:#21262d;--color-neutral-muted:rgba(110,118,129,.4);--color-accent-fg:#58a6ff;--color-accent-emphasis:#1f6feb;--color-danger-fg:#f85149}}@media (prefers-color-scheme:dark){[data-color-mode=auto][data-dark-theme=dark]{--color-canvas-default-transparent:rgba(13,17,23,0);--color-prettylights-syntax-comment:#8b949e;--color-prettylights-syntax-constant:#79c0ff;--color-prettylights-syntax-entity:#d2a8ff;--color-prettylights-syntax-storage-modifier-import:#c9d1d9;--color-prettylights-syntax-entity-tag:#7ee787;--color-prettylights-syntax-keyword:#ff7b72;--color-prettylights-syntax-string:#a5d6ff;--color-prettylights-syntax-variable:#ffa657;--color-prettylights-syntax-string-regexp:#7ee787;--color-prettylights-syntax-constant-other-reference-link:#a5d6ff;--color-fg-default:#c9d1d9;--color-fg-muted:#8b949e;--color-canvas-default:#0d1117;--color-canvas-subtle:#161b22;--color-border-default:#30363d;--color-border-muted:#21262d;--color-neutral-muted:rgba(110,118,129,.4);--color-accent-fg:#58a6ff;--color-accent-emphasis:#1f6feb;--color-danger-fg:#f85149}}.markdown-body{word-wrap:break-word;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Helvetica,Arial,sans-serif,Apple Color Emoji,Segoe UI Emoji;font-size:16px;line-height:1.5}.markdown-body:before{content:"";display:table}.markdown-body:after{clear:both;content:"";display:table}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body .absent{color:var(--color-danger-fg)}.markdown-body .anchor{float:left;margin-left:-20px;padding-right:4px;line-height:1}.markdown-body .anchor:focus{outline:none}.markdown-body p,.markdown-body blockquote,.markdown-body ul,.markdown-body ol,.markdown-body dl,.markdown-body table,.markdown-body pre,.markdown-body details{margin-top:0;margin-bottom:16px}.markdown-body hr{height:.25em;background-color:var(--color-border-default);border:0;margin:24px 0;padding:0}.markdown-body blockquote{color:var(--color-fg-muted);border-left:.25em solid var(--color-border-default);padding:0 1em}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1 .octicon-link,.markdown-body h2 .octicon-link,.markdown-body h3 .octicon-link,.markdown-body h4 .octicon-link,.markdown-body h5 .octicon-link,.markdown-body h6 .octicon-link{color:var(--color-fg-default);vertical-align:middle;visibility:hidden}.markdown-body h1:hover .anchor,.markdown-body h2:hover .anchor,.markdown-body h3:hover .anchor,.markdown-body h4:hover .anchor,.markdown-body h5:hover .anchor,.markdown-body h6:hover .anchor{text-decoration:none}.markdown-body h1:hover .anchor .octicon-link,.markdown-body h2:hover .anchor .octicon-link,.markdown-body h3:hover .anchor .octicon-link,.markdown-body h4:hover .anchor .octicon-link,.markdown-body h5:hover .anchor .octicon-link,.markdown-body h6:hover .anchor .octicon-link{visibility:visible}.markdown-body h1 tt,.markdown-body h1 code,.markdown-body h2 tt,.markdown-body h2 code,.markdown-body h3 tt,.markdown-body h3 code,.markdown-body h4 tt,.markdown-body h4 code,.markdown-body h5 tt,.markdown-body h5 code,.markdown-body h6 tt,.markdown-body h6 code{font-size:inherit;padding:0 .2em}.markdown-body h1{border-bottom:1px solid var(--color-border-muted);padding-bottom:.3em;font-size:2em}.markdown-body h2{border-bottom:1px solid var(--color-border-muted);padding-bottom:.3em;font-size:1.5em}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{color:var(--color-fg-muted);font-size:.85em}.markdown-body summary h1,.markdown-body summary h2,.markdown-body summary h3,.markdown-body summary h4,.markdown-body summary h5,.markdown-body summary h6{display:inline-block}.markdown-body summary h1 .anchor,.markdown-body summary h2 .anchor,.markdown-body summary h3 .anchor,.markdown-body summary h4 .anchor,.markdown-body summary h5 .anchor,.markdown-body summary h6 .anchor{margin-left:-40px}.markdown-body summary h1,.markdown-body summary h2{border-bottom:0;padding-bottom:0}.markdown-body ul,.markdown-body ol{padding-left:2em}.markdown-body ul.no-list,.markdown-body ol.no-list{padding:0;list-style-type:none}.markdown-body ol[type="1"]{list-style-type:decimal}.markdown-body ol[type=a]{list-style-type:lower-alpha}.markdown-body ol[type=i]{list-style-type:lower-roman}.markdown-body div>ol:not([type]){list-style-type:decimal}.markdown-body ul ul,.markdown-body ul ol,.markdown-body ol ol,.markdown-body ol ul{margin-top:0;margin-bottom:0}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dl{padding:0}.markdown-body dl dt{margin-top:16px;padding:0;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{margin-bottom:16px;padding:0 16px}.markdown-body table{width:100%;width:-webkit-max-content;width:-webkit-max-content;width:max-content;max-width:100%;display:block;overflow:auto}.markdown-body table th{font-weight:600}.markdown-body table th,.markdown-body table td{border:1px solid var(--color-border-default);padding:6px 13px}.markdown-body table tr{background-color:var(--color-canvas-default);border-top:1px solid var(--color-border-muted)}.markdown-body table tr:nth-child(2n){background-color:var(--color-canvas-subtle)}.markdown-body table img{background-color:rgba(0,0,0,0)}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:var(--color-canvas-default)}.markdown-body img[align=right]{padding-left:20px}.markdown-body img[align=left]{padding-right:20px}.markdown-body .emoji{max-width:none;vertical-align:text-top;background-color:rgba(0,0,0,0)}.markdown-body span.frame{display:block;overflow:hidden}.markdown-body span.frame>span{float:left;width:auto;border:1px solid var(--color-border-default);margin:13px 0 0;padding:7px;display:block;overflow:hidden}.markdown-body span.frame span img{float:left;display:block}.markdown-body span.frame span span{clear:both;color:var(--color-fg-default);padding:5px 0 0;display:block}.markdown-body span.align-center{clear:both;display:block;overflow:hidden}.markdown-body span.align-center>span{text-align:center;margin:13px auto 0;display:block;overflow:hidden}.markdown-body span.align-center span img{text-align:center;margin:0 auto}.markdown-body span.align-right{clear:both;display:block;overflow:hidden}.markdown-body span.align-right>span{text-align:right;margin:13px 0 0;display:block;overflow:hidden}.markdown-body span.align-right span img{text-align:right;margin:0}.markdown-body span.float-left{float:left;margin-right:13px;display:block;overflow:hidden}.markdown-body span.float-left span{margin:13px 0 0}.markdown-body span.float-right{float:right;margin-left:13px;display:block;overflow:hidden}.markdown-body span.float-right>span{text-align:right;margin:13px auto 0;display:block;overflow:hidden}.markdown-body code,.markdown-body tt{background-color:var(--color-neutral-muted);border-radius:6px;margin:0;padding:.2em .4em;font-size:85%}.markdown-body code br,.markdown-body tt br{display:none}.markdown-body del code{-webkit-text-decoration:inherit;-webkit-text-decoration:inherit;text-decoration:inherit}.markdown-body samp{font-size:85%}.markdown-body pre{word-wrap:normal}.markdown-body pre code{font-size:100%}.markdown-body pre>code{word-break:normal;white-space:pre;background:0 0;border:0;margin:0;padding:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{word-break:normal;margin-bottom:0}.markdown-body .highlight pre,.markdown-body pre{background-color:var(--color-canvas-subtle);border-radius:6px;padding:16px;font-size:85%;line-height:1.45;overflow:auto}.markdown-body pre code,.markdown-body pre tt{max-width:auto;line-height:inherit;word-wrap:normal;background-color:rgba(0,0,0,0);border:0;margin:0;padding:0;display:inline;overflow:visible}.markdown-body .csv-data td,.markdown-body .csv-data th{text-align:left;white-space:nowrap;padding:5px;font-size:12px;line-height:1;overflow:hidden}.markdown-body .csv-data .blob-num{text-align:right;background:var(--color-canvas-default);border:0;padding:10px 8px 9px}.markdown-body .csv-data tr{border-top:0}.markdown-body .csv-data th{background:var(--color-canvas-subtle);border-top:0;font-weight:600}.markdown-body [data-footnote-ref]:before{content:"["}.markdown-body [data-footnote-ref]:after{content:"]"}.markdown-body .footnotes{color:var(--color-fg-muted);border-top:1px solid var(--color-border-default);font-size:12px}.markdown-body .footnotes ol{padding-left:16px}.markdown-body .footnotes li{position:relative}.markdown-body .footnotes li:target:before{pointer-events:none;content:"";border:2px solid var(--color-accent-emphasis);border-radius:6px;position:absolute;top:-8px;bottom:-8px;left:-24px;right:-8px}.markdown-body .footnotes li:target{color:var(--color-fg-default)}.markdown-body .footnotes .data-footnote-backref g-emoji{font-family:monospace}.markdown-body{background-color:var(--color-canvas-default);color:var(--color-fg-default)}.markdown-body a{color:var(--color-accent-fg);text-decoration:none}.markdown-body a:hover{text-decoration:underline}.markdown-body iframe{background-color:#fff;border:0;margin-bottom:16px}.markdown-body svg.octicon{fill:currentColor}.markdown-body .anchor>.octicon{display:inline}.markdown-body .highlight .token.keyword,.gfm-highlight .token.keyword{color:var(--color-prettylights-syntax-keyword)}.markdown-body .highlight .token.tag .token.class-name,.markdown-body .highlight .token.tag .token.script .token.punctuation,.gfm-highlight .token.tag .token.class-name,.gfm-highlight .token.tag .token.script .token.punctuation{color:var(--color-prettylights-syntax-storage-modifier-import)}.markdown-body .highlight .token.operator,.markdown-body .highlight .token.number,.markdown-body .highlight .token.boolean,.markdown-body .highlight .token.tag .token.punctuation,.markdown-body .highlight .token.tag .token.script .token.script-punctuation,.markdown-body .highlight .token.tag .token.attr-name,.gfm-highlight .token.operator,.gfm-highlight .token.number,.gfm-highlight .token.boolean,.gfm-highlight .token.tag .token.punctuation,.gfm-highlight .token.tag .token.script .token.script-punctuation,.gfm-highlight .token.tag .token.attr-name{color:var(--color-prettylights-syntax-constant)}.markdown-body .highlight .token.function,.gfm-highlight .token.function{color:var(--color-prettylights-syntax-entity)}.markdown-body .highlight .token.string,.gfm-highlight .token.string{color:var(--color-prettylights-syntax-string)}.markdown-body .highlight .token.comment,.gfm-highlight .token.comment{color:var(--color-prettylights-syntax-comment)}.markdown-body .highlight .token.class-name,.gfm-highlight .token.class-name{color:var(--color-prettylights-syntax-variable)}.markdown-body .highlight .token.regex,.gfm-highlight .token.regex{color:var(--color-prettylights-syntax-string)}.markdown-body .highlight .token.regex .regex-delimiter,.gfm-highlight .token.regex .regex-delimiter{color:var(--color-prettylights-syntax-constant)}.markdown-body .highlight .token.tag .token.tag,.markdown-body .highlight .token.property,.gfm-highlight .token.tag .token.tag,.gfm-highlight .token.property{color:var(--color-prettylights-syntax-entity-tag)}
    </style>
  </head>
  <body>
    <main data-color-mode="light" data-light-theme="light" data-dark-theme="dark" class="markdown-body">
      <h1>Awesome Glp1 Overview</h1>
<p>Awesome resources around the GLP1 Receptor Agonist class of treatments. Sponsored by GLP1.Guide</p>
<p><a href="/">üè† Home</a><span> ¬∑ </span><a href="https://www.trackawesomelist.com/glp1guide/awesome-glp1/rss.xml">üî• Feed</a><span> ¬∑ </span><a href="https://trackawesomelist.us17.list-manage.com/subscribe?u=d2f0117aa829c83a63ec63c2f&id=36a103854c">üìÆ Subscribe</a><span> ¬∑ </span><a href="https://github.com/sponsors/theowenyoung">‚ù§Ô∏è  Sponsor</a><span> ¬∑ </span><a href="https://github.com/glp1guide/awesome-glp1">üò∫ glp1guide/awesome-glp1</a><span> ¬∑ </span><span>‚≠ê 3</span><span> ¬∑ </span><span>üè∑Ô∏è Miscellaneous</span></p>
<p><span>[ </span><a href="/glp1guide/awesome-glp1/">Daily</a><span> / </span><a href="/glp1guide/awesome-glp1/week/">Weekly</a><span> / </span><span>Overview</span><span> ]</span></p>
<h1 id="üíä-awesome-glp1"><a class="anchor" aria-hidden="true" tabindex="-1" href="#üíä-awesome-glp1"><svg class="octicon octicon-link" viewbox="0 0 16 16" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>üíä Awesome GLP1</h1><div>
  <h3>Sponsored &amp; maintained By</h3>
<a href="https://glp1.guide?ref=github"><img src="https://github.com/glp1guide/awesome-glp1/raw/main/images/glp1-guide-banner.600x256.jpg" alt="glp1.guide banner" height="100px" /></a>
</div>

<p><a href="https://glp1.guide/content/what-are-glp1-agonists" rel="noopener noreferrer">GLP1 Receptor Agonists</a> are awesome.
They're not magic, and they don't work for everyone, and they're not the right <em>choice</em> for everyone, but for those they help, they're an amazing solution.</p>
<p>This repo holds all the awesome research, data, compiled anecdata, and resources for people who want to learn more about the GLP1 Receptor Agonist class of treatments.</p>
<h1 id="üìë-research"><a class="anchor" aria-hidden="true" tabindex="-1" href="#üìë-research"><svg class="octicon octicon-link" viewbox="0 0 16 16" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>üìë Research</h1><p>One of the best things about GLP1 treatments is that they are <em>well researched</em>. Here are some of the best pieces of research we've found.</p>
<h2 id="üßëü§ùüßë-trials"><a class="anchor" aria-hidden="true" tabindex="-1" href="#üßëü§ùüßë-trials"><svg class="octicon octicon-link" viewbox="0 0 16 16" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>üßë‚Äçü§ù‚Äçüßë Trials</h2><p>One of the best things about GLP1 Receptor Agonists is that they are <em>well studied</em>.
Don't forget to look at conflicts of interest listings -- some trials are funded by companies that manufacture formulations of GLP1.</p>
<ul>
<li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2032183" rel="noopener noreferrer">STEP1 Trial</a> (Semaglutide)<ul>
<li><a href="https://clinicaltrials.gov/study/NCT03548935" rel="noopener noreferrer">On ClinicalTrials.gov</a></li>
</ul>
</li>
<li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00213-0/abstract" rel="noopener noreferrer">Step2 Trial</a> (Semaglutide)</li>
<li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2206038" rel="noopener noreferrer">SURMOUNT-1 Trial</a> (Tirzepatide)</li>
<li><a href="https://jamanetwork.com/journals/jama/fullarticle/2812936" rel="noopener noreferrer">SURMOUNT-4 Trial</a></li>
</ul>
<h1 id="üåê-official-manufacturer-websites"><a class="anchor" aria-hidden="true" tabindex="-1" href="#üåê-official-manufacturer-websites"><svg class="octicon octicon-link" viewbox="0 0 16 16" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>üåê Official manufacturer websites</h1><p>Here are the official websites of different formulations of GLP1 Receptor Agonists:</p>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Peptide Name</th>
<th>Manufacturer</th>
</tr>
</thead>
<tbody><tr>
<td>[Ozempic][ozempic]</td>
<td>Semaglutide</td>
<td>[Novo Nordisk][nn]</td>
</tr>
<tr>
<td>[Wegovy][wegovy]</td>
<td>Semaglutide</td>
<td>[Novo Nordisk][nn]</td>
</tr>
<tr>
<td>[Mounjaro][mounjaro]</td>
<td>Tirzepatide</td>
<td>[Eli Lilly][lilly]</td>
</tr>
<tr>
<td>[Zepbound][zepbound]</td>
<td>Tirzepatide</td>
<td>[Eli Lilly][lilly]</td>
</tr>
<tr>
<td>[Rybelsus][rybelsus]</td>
<td>Semaglutide</td>
<td>[Novo Nordisk][nn]</td>
</tr>
<tr>
<td>[Victoza][victoza]</td>
<td>Liraglutide</td>
<td>[Novo Nordisk][nn]</td>
</tr>
<tr>
<td>[Saxenda][saxenda]</td>
<td>Liraglutide</td>
<td>[Novo Nordisk][nn]</td>
</tr>
<tr>
<td>[Trulicity][trulicity]</td>
<td>Dulaglutide</td>
<td>[Eli Lily][lilly]</td>
</tr>
<tr>
<td>[Byetta][byetta]</td>
<td>Exenatide</td>
<td>[Astra Zeneca][az]</td>
</tr>
</tbody></table>
<blockquote>
<p>![WARNING]
We do not recommend getting formulations of Semaglutide/Tirzepatide/etc from <em>non-official sources</em>, like compounding operations.
It is risky, and the repercussions are unknown and highy dangerous.
Always consult your doctor/medical health professional before starting a regimen.</p>
</blockquote>
<h1 id="ü§ó-contributing"><a class="anchor" aria-hidden="true" tabindex="-1" href="#ü§ó-contributing"><svg class="octicon octicon-link" viewbox="0 0 16 16" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>ü§ó Contributing</h1><p>Found something we've missed, or have more to add?</p>
<p>Make some edits to this file (or any other file) and <a href="https://github.com/glp1guide/awesome-glp1/issues" rel="noopener noreferrer">file an issue</a> or <a href="https://github.com/glp1guide/awesome-glp1/pulls" rel="noopener noreferrer">open a pull request directly</a> and we'd be happy to help!</p>


    </main>
  </body>
</html>
